EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unraveling trajectories from aplastic anemia to hematologic malignancies: genetic and molecular insights

Namsoo Kim, Yu Jeong Choi, Seung-Tae Lee, Jong Rak Choi, Chuhl Joo Lyu, Saeam Shin, June-Won Cheong

Frontiers in Oncology · 13.03.2024 · 14

DOI: 10.3389/fonc.2024.1365614 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 13.03.2024. Verfasst von Namsoo Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Aplastic anemia (AA), characterized by hematopoietic stem cell deficiency, can evolve into different hematologic malignancies. Our understanding of the genetic basis and mechanisms of this progression remains limited.

Methods

We retrospectively studied 9 acquired AA patients who later developed hematologic malignancies. Data encompassed clinical, laboratory, karyotype, and next-generation sequencing (NGS) information. We explored chromosomal alterations and mutation profiles to uncover genetic changes underlying the transition.

Results

Nine AA patients developed myelodysplastic syndrome (seven patients), acute myeloid leukemia (one patient), or chronic myelomonocytic leukemia (one patient). Among eight patients with karyotype results at secondary malignancy diagnosis, monosomy 7 was detected in three. Trisomy 1, der(1;7), del(6q), trisomy 8, and del(12p) were detected in one patient each. Among three patients with NGS results at secondary malignancy diagnosis, KMT2C mutation was detected in two patients. Acquisition of a PTPN11 mutation was observed in one patient who underwent follow-up NGS testing during progression from chronic myelomonocytic leukemia to acute myeloid leukemia.

Conclusion

This study highlights the genetic dynamics in the progression from AA to hematologic malignancy. Monosomy 7’s prevalence and the occurrence of PTPN11 mutations suggest predictive and prognostic significance. Clonal evolution underscores the complexity of disease progression.

Schlagwörter

Stichwörter der Autor:innen

aplastic anemiaclonal evolutiongenomic profilehematologic malignancysecondary cancer

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Dxome Co. Ltd., Seongnam-si, Gyeonggi-do, Republic of Korea.
  • Department of Pediatric Hematology-Oncology, Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea.

Zitieren

APA

Kim, N., Choi, Y. J., Lee, S. T., Choi, J. R., Lyu, C. J., Shin, S., & Cheong, J. W. (2024). Unraveling trajectories from aplastic anemia to hematologic malignancies: genetic and molecular insights. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1365614

Vancouver

Kim N, Choi YJ, Lee ST, Choi JR, Lyu CJ, Shin S, et al. Unraveling trajectories from aplastic anemia to hematologic malignancies: genetic and molecular insights. Frontiers in Oncology. 2024;14. doi:10.3389/fonc.2024.1365614

BibTeX
@article{Kim2024,
  author = {Kim, Namsoo and Choi, Yu Jeong and Lee, Seung-Tae and Choi, Jong Rak and Lyu, Chuhl Joo and Shin, Saeam and Cheong, June-Won},
  title = {Unraveling trajectories from aplastic anemia to hematologic malignancies: genetic and molecular insights},
  journal = {Frontiers in Oncology},
  year = {2024},
  volume = {14},
  doi = {10.3389/fonc.2024.1365614}
}
Kostenlos starten →